Skip to main content

Table 2 Pathway enrichment analysis of genes selected by the G-4, T-4, and TI-4 models when predicting OS (no pathways were significantly enriched for EFS)

From: Predicting survival times for neuroblastoma patients using RNA-seq expression profiles

Outcome Pathway Count Size P-value BH
OS Pathways in cancer 26 393 <0.001 0.010
OS ErbB signaling pathway 11 87 <0.001 0.012
  1. The columns include KEGG pathway name, the number of genes in the gene set that are in the pathway, the total number of genes annotated for the pathway, the p-value from a modified fisher’s exact test, and the Benjamini-Hochberg corrected p-value